166 related articles for article (PubMed ID: 17371950)
1. Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone.
Choi S; Henderson MJ; Kwan E; Beesley AH; Sutton R; Bahar AY; Giles J; Venn NC; Pozza LD; Baker DL; Marshall GM; Kees UR; Haber M; Norris MD
Blood; 2007 Jul; 110(2):632-9. PubMed ID: 17371950
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of relapse in pediatric acute lymphoblastic leukemia.
Henderson MJ; Choi S; Beesley AH; Sutton R; Venn NC; Marshall GM; Kees UR; Haber M; Norris MD
Cell Cycle; 2008 May; 7(10):1315-20. PubMed ID: 18418081
[TBL] [Abstract][Full Text] [Related]
3. Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy.
de Haas V; Verhagen OJ; von dem Borne AE; Kroes W; van den Berg H; van der Schoot CE
Leukemia; 2001 Jan; 15(1):134-40. PubMed ID: 11243381
[TBL] [Abstract][Full Text] [Related]
4. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.
Konrad M; Metzler M; Panzer S; Ostreicher I; Peham M; Repp R; Haas OA; Gadner H; Panzer-Grumayer ER
Blood; 2003 May; 101(9):3635-40. PubMed ID: 12506024
[TBL] [Abstract][Full Text] [Related]
5. Tracing back of relapse clones by Ig/TCR gene rearrangements reveals complex patterns of recurrence in pediatric acute lymphoblastic leukemia.
Jia MZ; Li WJ; Wang CJ; Zhang Q; Gao C; Huang XT; Zhu T; Zhang RD; Cui L; Li ZG
Int J Lab Hematol; 2023 Oct; 45(5):717-725. PubMed ID: 37194559
[TBL] [Abstract][Full Text] [Related]
6. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dye.
Li AH; Forestier E; Rosenquist R; Roos G
Exp Hematol; 2002 Oct; 30(10):1170-7. PubMed ID: 12384148
[TBL] [Abstract][Full Text] [Related]
8. Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection.
Li A; Zhou J; Zuckerman D; Rue M; Dalton V; Lyons C; Silverman LB; Sallan SE; Gribben JG
Blood; 2003 Dec; 102(13):4520-6. PubMed ID: 12946997
[TBL] [Abstract][Full Text] [Related]
9. Antigen receptor sequencing of paired bone marrow samples shows homogeneous distribution of acute lymphoblastic leukemia subclones.
Theunissen PMJ; van Zessen D; Stubbs AP; Faham M; Zwaan CM; van Dongen JJM; Van Der Velden VHJ
Haematologica; 2017 Nov; 102(11):1869-1877. PubMed ID: 28860343
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
Brisco MJ; Condon J; Hughes E; Neoh SH; Nicholson I; Sykes PJ; Tauro G; Ekert H; Waters K; Toogood I
Leukemia; 1993 Oct; 7(10):1514-20. PubMed ID: 8412313
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements.
Cole-Sinclair M; Foroni L; Wright F; Mehta A; Prentice HG; Hoffbrand AV
Leuk Lymphoma; 1993; 11 Suppl 2():49-58. PubMed ID: 8124233
[TBL] [Abstract][Full Text] [Related]
12. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
[TBL] [Abstract][Full Text] [Related]
13. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
[TBL] [Abstract][Full Text] [Related]
14. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of non-concordance in the T-cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia.
Taylor JJ; Rowe D; Kylefjord H; Chessells J; Katz F; Proctor SJ; Middleton PG
Leukemia; 1994 Jan; 8(1):60-6. PubMed ID: 8289500
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
[TBL] [Abstract][Full Text] [Related]
17. Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice.
Steenbergen EJ; Verhagen OJ; Nibbering CP; van den Berg H; van Leeuwen EF; Behrendt H; von dem Borne AE; van der Schoot CE
Leukemia; 1996 Sep; 10(9):1471-8. PubMed ID: 8751465
[TBL] [Abstract][Full Text] [Related]
18. Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia.
Fasching K; Panzer S; Haas OA; Marschalek R; Gadner H; Panzer-Grümayer ER
Blood; 2000 Apr; 95(8):2722-4. PubMed ID: 10753857
[TBL] [Abstract][Full Text] [Related]
19. Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.
Marshall GM; Kwan E; Haber M; Brisco MJ; Sykes PJ; Morley AA; Toogood I; Waters K; Tauro G; Ekert H
Leukemia; 1995 Nov; 9(11):1847-50. PubMed ID: 7475273
[TBL] [Abstract][Full Text] [Related]
20. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
Seriu T; Yokota S; Nakao M; Misawa S; Takaue Y; Koizumi S; Kawai S; Fujimoto T
Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
